Nurexone Biologic Liabilities 2024

Liabilities Details

Assessing Nurexone Biologic's Liabilities

Nurexone Biologic's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Nurexone Biologic's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Nurexone Biologic's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Nurexone Biologic's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Nurexone Biologic’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Nurexone Biologic Stock

What is the level of liabilities of Nurexone Biologic this year?

Nurexone Biologic has a debt balance of 0 USD this year.

What were the liabilities of Nurexone Biologic compared to the previous year?

The liabilities of Nurexone Biologic have increased by -100% dropped compared to the previous year.

What are the consequences of high debt for investors of Nurexone Biologic?

High liabilities can pose a risk for investors of Nurexone Biologic, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Nurexone Biologic?

Low liabilities mean that Nurexone Biologic has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Nurexone Biologic affect the company?

An increase in liabilities of Nurexone Biologic can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Nurexone Biologic affect the company?

A decrease in the liabilities of Nurexone Biologic can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Nurexone Biologic?

Some factors that can influence the liabilities of Nurexone Biologic include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Nurexone Biologic so important for investors?

The liabilities of Nurexone Biologic are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Nurexone Biologic take to modify the liabilities?

To change its liabilities, Nurexone Biologic can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Nurexone Biologic pay?

Over the past 12 months, Nurexone Biologic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nurexone Biologic is expected to pay a dividend of 0 USD.

What is the dividend yield of Nurexone Biologic?

The current dividend yield of Nurexone Biologic is .

When does Nurexone Biologic pay dividends?

Nurexone Biologic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nurexone Biologic?

Nurexone Biologic paid dividends every year for the past 0 years.

What is the dividend of Nurexone Biologic?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nurexone Biologic located?

Nurexone Biologic is assigned to the '-' sector.

Wann musste ich die Aktien von Nurexone Biologic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nurexone Biologic from 6/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/10/2024.

When did Nurexone Biologic pay the last dividend?

The last dividend was paid out on 6/10/2024.

What was the dividend of Nurexone Biologic in the year 2023?

In the year 2023, Nurexone Biologic distributed 0 USD as dividends.

In which currency does Nurexone Biologic pay out the dividend?

The dividends of Nurexone Biologic are distributed in USD.